Latest Blogs

Jan 16, 2019
Dr. Jean Rene V. Clemenceau Valdivia describes the shared history of the Sociedad Mexicana de Oncologia and ASCO, and the new formal partnership that will guide future collaboration between the two societies.
Jan 14, 2019
Social injustice is perpetuated when patients can't afford to participate in essential clinical research.
Jan 08, 2019
Although there’s never a bad time to make a positive commitment in your life, something about opening the calendar to January 1 feels like the right moment to set an intention.
Jan 03, 2019
Dr. Pesona Grace Lucksom's career journey has been shaped by a series of battles with hormones and their impact on women's health, and this is a fight she intends to win.
Subscribe to this column

Don S. Dizon, MD, FACP, FASCO

Don S. Dizon, MD, FACP, FASCO, is head of Women's Cancers at Lifespan Cancer Institute, director of Medical Oncology at Rhode Island Hospital, and a professor of medicine at The Warren Alpert Medical School of Brown University. Dr. Dizon serves as chair of ASCO's Social Media Working Group and is a past chair of the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for The Oncologist and a section editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the Journal of Clinical Oncology Editorial Board, and editor in chief of the ASCO Educational BookFollow Dr. Dizon on Twitter @drdonsdizon.

Apr 27, 2017
When you see enough remarkable recoveries, it becomes tempting to believe it is not only the drugs—that it is you. Where there is the Lazarus effect, perhaps there is the resurgence of the God complex as well.
Mar 31, 2017
When a dying patient wanted more time at any cost, and our team collectively felt that a code would be inhumane, an ethics consultation helped provide clarity and support for our decision-making.
Mar 16, 2017
I tend to be cautious with the word cure, because sometimes that is the only thing that patients hear.
Feb 23, 2017
When the travel ban was announced, I worried for my patients and for my colleagues. I worried that medical care would be denied to international patients, including those who came to the U.S. for cancer care.
Feb 02, 2017
When it comes to many alternative therapies, the data is too sparse to inform discussions on benefits and/or risks, as my patient learned when her supplement use prevented her from continuing on a clinical trial.
Dec 27, 2016
With new therapies, fortunately, oncologists are now seeing patients over the span of years, and we get to know the person who is the patient beyond their illness. Many also bring along others on visit after visit, and we get to know each of them too.

Pages